Return to homepagePandemic Pact

Angiotensin (1,7) in the treatment of COVID-19 patients: the ATCO study

Grant number: APQ-00325-20

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $17,454.25

  • Funder

    FAPEMIG Brazil

  • Principal Investigator

    Robson Augusto Souza Dos Santos

  • Research Location

    Brazil

  • Lead Research Institution

    Universidade Federal de Minas Gerais

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

ACE2/Angiotensin-(1-7)/Mas and the brain.

Angiotensin-(1-7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1-2 randomized clinical trial.